Thomas Sudhop

4.4k citations
61 papers · 3.3k indexed · 1 hit paper · h-index 30

Impact in

  • Hepatology top 2%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
  • Surgery top 2%
    • Cholesterol and Lipid Metabolism
    • Lipoproteins and Cardiovascular Health

Papers in

    • Liver Disease and Transplantation 5
    • Cholesterol and Lipid Metabolism 19
    • Lipoproteins and Cardiovascular Health 11

Thomas Sudhop

59 papers receiving 3.1k citations

Hit Papers

Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans 2002 · 527 citations
5272002202620102018100200300400500

Peers

Thomas Sudhop
Comparison fields: 5 of 128
  • Hepatology 405
  • Surgery 1.7k
  • Endocrine and Autonomic Systems 191
  • Endocrinology, Diabetes and Metabolism 426
  • Pharmacology 218
Replace Jamal A. Ibdah with:
Jamal A. Ibdah United States
Daniele Pastori Italy
Hiroyuki Sato Japan
Shigekazu Takemura Japan
Evangelos Liberopoulos Greece
Francesco Angelico Italy
Cheol Whee Park South Korea
Lorenzo Loffredo Italy
Maria Del Ben Italy
Cristina Nocella Italy
Thomas Sudhop relative to Jamal A. Ibdah United States Jamal A. Ibdah's profile →
Citations per field
00.5×1.5×1.8×
Jamal A. Ibdah · 1×
Citations per year

Countries citing papers authored by Thomas Sudhop

Since Specialization
Citations

This map shows the geographic impact of Thomas Sudhop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Sudhop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Sudhop more than expected).

Fields of papers citing papers by Thomas Sudhop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Sudhop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Sudhop. The network helps show where Thomas Sudhop may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Sudhop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Sudhop Line = papers co-authored together Thomas Sudhop links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20192
2 20179
3 20176
4 201716
5 20153
6 2008128
7 20075
8 200622
9 200632
10 200461
11 200430
12 200451
13 200353
14 200271
15 2002279
16 200155
17 20008
18 199834
19 1998156
20 19963

About Thomas Sudhop

Thomas Sudhop is a scholar working on Hepatology, Surgery, Pharmacology, Gastroenterology and Oncology, having authored 61 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (19 papers), Drug Transport and Resistance Mechanisms (12 papers), Lipoproteins and Cardiovascular Health (11 papers), Liver Disease Diagnosis and Treatment (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Liver Disease and Transplantation (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). The work is most often cited by research in Hepatology (405 citations), Surgery (1.7k citations), Endocrine and Autonomic Systems (191 citations), Endocrinology, Diabetes and Metabolism (426 citations) and Pharmacology (218 citations). Thomas Sudhop has collaborated with scholars based in Germany, United States and Panama. Frequent co-authors include Klaus von Bergmann, Dieter Lütjohann, Heiner K. Berthold, Michael Igel, Diane L. Tribble, Inna Perevozskaya, Sukrut Shah, Santiago Ewig, Tilman Sauerbruch and Ioanna Gouni‐Berthold. Their work appears in journals such as European Journal of Clinical Pharmacology, Journal of Lipid Research, Epilepsia, European Journal of Gastroenterology & Hepatology and Atherosclerosis Supplements.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026